MaaT Pharma SA (EPA:MAAT)

MaaT Pharma Revenue

MaaT Pharma had revenue of 1.08M EUR in the half year ending June 30, 2026, a decrease of -37.30%. This brings the company's total for the last twelve months to 3.18M, down -19.02% year-over-year. In the year 2025, MaaT Pharma had annual revenue of 4.52M with 40.67% growth. That makes MaaT Pharma the 40,960th largest company in the world by revenue and 543rd in France.

• Revenue (ttm): 3.18M
• Revenue Growth: -19.02%
• P/S Ratio: 6.30
• Revenue / Employee: 52.93K
• Employees: 60
• Market Cap: 20.01M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• France 4.46M 98.5%
• Export and Intra-Community 67.27K 1.5%

Fiscal year ended Dec 31, 2025 See the full MaaT Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.52M	1.31M	40.67%
Dec 31, 2024	3.22M	987.74K	44.33%
Dec 31, 2023	2.23M	798.26K	55.82%
Dec 31, 2022	1.43M	458.28K	47.16%
Dec 31, 2021	971.73K	310.09K	46.87%
Dec 31, 2020	661.64K	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Sep 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Semi-annually

Last checked:

Oct 20, 2026

Data Sources Report a data error